HIGHLIGHTS
- who: PELICAN (PrEgabalin Lidocaine Capsaicin et al. from the Multidisciplinary Center, Antwerp University Hospital (UZA), Edegem have published the research work: Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study, in the Journal: Pain Research and Management of 14/04/2023
- what: Te study was designed to compare topical and systemic medications according to the observed improvement in quality of life, pain relief, and occurrence of adverse efects.
- how: Within 8 weeks of the initial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.